Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting

Core outcome set measurement for future clinical trials in acute myeloid leukemia: the HARMONY study protocol using a multi-stakeholder consensus-based Delphi process and a final consensus meeting

Abstract Background Acute myeloid leukemia (AML) is the most common acute leukemia in adults and has an unacceptably low cure rate. In recent years, a number of new treatment strategies and compounds were developed for the treatment of AML. There were several randomized controlled clinical trials wi...

Full description

Bibliographic Details
Main Authors: Katharina M. Lang, Kathryn L. Harrison, Paula R. Williamson, Brian J. P. Huntly, Gert Ossenkoppele, Jan Geissler, Tamàs Bereczky, Jesús M. Hernández-Rivas, Hélène Chevrou-Séverac, Rory Goodbody, Renate Schulze-Rath, Lars Bullinger
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Trials
Subjects:
Delphi process
Core outcome set
Acute myeloid leukemia
Online Access:http://link.springer.com/article/10.1186/s13063-020-04384-1

Internet

http://link.springer.com/article/10.1186/s13063-020-04384-1

Similar Items